Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (341-350 of 1,058) with videos related to

Pageof 106
Sort By:
Journal of the American Society for Mass Spectrometry|December 31, 2003
Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLiwen Zhang, Michael A Freitas, Joseph Wickham, et al.
Annals of Internal Medicine|August 15, 1994
Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleedingA R Wiesen, D R Hospenthal, J C Byrd, et al.
American Journal of Hematology|June 1, 1995
Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxisJ C Byrd, J B Hargis, K E Kester, et al.
The Journal of Biological Chemistry|April 15, 1989
Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphismJ R Gum, J C Byrd, J W Hicks, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2019
Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemiaAbigail S Robbertz, David M Weiss, Farrukh T Awan, et al.
Cell Death & Disease|August 12, 2016
Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristicsMatthias Ilmer, Nachman Mazurek, James C Byrd, et al.
NAR Genomics and Bioinformatics|October 12, 2020
Characterization and mitigation of fragmentation enzyme-induced dual stranded artifactsThomas Gregory, Apollinaire Ngankeu, Shelley Orwick, et al.
Blood|February 22, 2003
KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosisJohn C Byrd, David M Lucas, Andrew P Mone, et al.
Molecular Biosystems|April 29, 2014
Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysisSarah Schwartz Baxter, Christopher F Dibble, Warren C Byrd, et al.
Inorganic Chemistry|May 10, 2021
Heterocyclic Nitrilimines and Their Use in the Synthesis of Complex High-Nitrogen MaterialsMatthew L Gettings, Sarah E Davis Finch, Ashank Sethia, et al.
Pageof 106

Showing results (341-350 of 1,058) with videos related to

Sort By:
Pageof 106
Journal of the American Society for Mass Spectrometry|December 31, 2003
Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLiwen Zhang, Michael A Freitas, Joseph Wickham, et al.
Annals of Internal Medicine|August 15, 1994
Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleedingA R Wiesen, D R Hospenthal, J C Byrd, et al.
American Journal of Hematology|June 1, 1995
Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxisJ C Byrd, J B Hargis, K E Kester, et al.
The Journal of Biological Chemistry|April 15, 1989
Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphismJ R Gum, J C Byrd, J W Hicks, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2019
Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemiaAbigail S Robbertz, David M Weiss, Farrukh T Awan, et al.
Cell Death & Disease|August 12, 2016
Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristicsMatthias Ilmer, Nachman Mazurek, James C Byrd, et al.
NAR Genomics and Bioinformatics|October 12, 2020
Characterization and mitigation of fragmentation enzyme-induced dual stranded artifactsThomas Gregory, Apollinaire Ngankeu, Shelley Orwick, et al.
Blood|February 22, 2003
KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosisJohn C Byrd, David M Lucas, Andrew P Mone, et al.
Molecular Biosystems|April 29, 2014
Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysisSarah Schwartz Baxter, Christopher F Dibble, Warren C Byrd, et al.
Inorganic Chemistry|May 10, 2021
Heterocyclic Nitrilimines and Their Use in the Synthesis of Complex High-Nitrogen MaterialsMatthew L Gettings, Sarah E Davis Finch, Ashank Sethia, et al.
Pageof 106